Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy.

Ganesh Yerra V, Negi G, Sharma SS, Kumar A. · 2013

Read Potential therapeutic effects of the simultaneous targeting of the Nrf2 and NF-κB pathways in diabetic neuropathy. by Ganesh Yerra V, Negi G, Sharma SS, Kumar A. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3757712.txt.

Description

Veera Ganesh Yerra, Geeta Negi, Shyam Sharma, and Ashutosh Kumar wrote a review in Redox Biology in 2013 on two pathways in diabetic neuropathy. Diabetic neuropathy, nerve damage from diabetes, affects roughly 40 to 50 percent of people with diabetes and ranges from numbness to burning pain. Two transcription factors sit on opposite sides of the problem.

Nrf2 drives the production of antioxidant defenses, while NF-kB drives inflammatory signals. In healthy cells the two are coordinated to keep chemical balance; in disease that coordination breaks down. Changes in both factors have been reported in diabetic neuropathy. The review sums up their roles and collects the treatment results of drugs aimed at the Nrf2-NF-kB axis, arguing that targeting both at once may help.

Catalog record

CREATORGanesh Yerra V, Negi G, Sharma SS, Kumar A.
YEAR2013
COLLECTIONPAPERS
FORMATTXT
FILE SIZE18 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC3757712

Browse the full library · About the Tower of Babel